Altered mitochondrial cytochrome b gene expression during the regression of hemangioma.
Hemangioma is a primary tumor of microvasculature. Its development typically exhibits a proliferative phase followed by an involuting phase that continues into the involuted phase. Although apoptosis has been reported, the mechanisms regulating the spontaneous regression of hemangioma are largely unknown. The authors recently demonstrated up-regulation of the mitochondrial cytochrome b gene in hemangioma associated with steroid-induced regression. The present study investigated whether a similar change occurred during spontaneous regression. Biopsy material was obtained from 11 patients with hemangiomas at different phases of development. In one of these patients, a biopsy was taken from the proliferative, involuting, and involuted areas of the hemangioma. In another patient, a biopsy was taken before and 5 weeks after the intralesional administration of steroids. From each tissue specimen, RNA was isolated and subjected to reverse transcriptase-polymerase chain reaction analysis by use of specific primers for the human mitochondrial cytochrome b gene. Semiquantitative reverse transcriptase-polymerase chain reaction analysis revealed that the strongest expression of the mitochondrial cytochrome b transcripts was in specimens taken from hemangiomas in the involuting phase compared with those from the proliferative and involuted phases. The authors concluded that mitochondrial cytochrome b is associated with both the spontaneous and the steroid-induced regression of hemangioma, probably by regulating apoptosis.
Hasan
Q
Q
Wellington Regional Plastic, Maxillofacial, and Burns Unit, Hutt Hospital, New Zealand.
Tan
S T
ST
Gush
J
J
Davis
P F
PF
D017209:Apoptosis; D002648:Child; D002675:Child, Preschool; D003573:Cytochrome b Group / Q000235:genetics*; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D005938:Glucocorticoids / Q000008:administration & dosage; D006391:Hemangioma / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D015552:Injections, Intralesional; D008297:Male; D012313:RNA / Q000235:genetics*; D000077278:RNA, Mitochondrial; D012075:Remission, Spontaneous; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012878:Skin Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D015854:Up-Regulation
D003573:Cytochrome b Group; D005938:Glucocorticoids; D000077278:RNA, Mitochondrial; D012313:RNA